Products
Platform
Research
Market
Learn
Partner
Support
IPO

C

Chandan Healthcare Share Price

251.75
-5.90 (-2.29%)
CHANDAN • 21 Jan, 2026 | 03:29 PM
The current prices are delayed, login or Open Demat Account for live prices.

Chandan Healthcare Stock Performance

1W Return-14.76
1Y Return0.00
Today's Low247
Prev. Close257.65
Mkt Cap (Cr.)630.01
1M Return-13.19
3Y Return0.00
52-Week High358
Open250.05
PE Ratio30.31
6M Return16.17
Today's High262
52-Week Low140
Face Value10

Chandan Healthcare Company background

Founded in: 2003
Managing director: Amar Singh
Chandan Healthcare Limited, established on September 03, 2003, specializes in operating stateoftheart laboratories that offer comprehensive pathological investigations. The Company run a diagnostic network in North India with pathology and radiology testing services. Their services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, Xrays, and MRIs. The Company commenced business by starting its first diagnostic centre in Indra Nagar, Lucknow in 2003. Later, it started the diagnostic centre in Dehradun in 2013. It has established a chain of Retail Pharmacies in Uttar Pradesh, Uttarakhand, and Delhi, along with wholesale distribution to our retail outlets and hospitals. Operating in Lucknow, Chandan Hospital Limited is a 300bed tertiary care MultiSuperspecialty Hospital that has quickly gained recognition as one of the leading hospitals in the region since its opening on October 1st, 2018.As of August 31, 2024, the Company has 1 flagship laboratory, 7 central laboratories, 26 satellite centres, more than 300 collection centres and located across India, with facilities in more than 15 cities and towns across Uttar Pradesh and more than 10 cities and towns in Uttarakhand. Out of various laboratories, 8 are National Accreditation Board for Testing and Calibration Laboratories (NABL) accredited while three of the diagnostic centres have National Accreditation Board for Hospitals Healthcare Providers (NABH) accreditation.Apart from these, the Company provide nearly 1,496 tests across different specialties. These test menu includes 481 routine pathology tests, covering basic biochemistry and hematology, as well as 1,015 specialized pathology tests, such as immohistopathology, and molecular pathology, and 545 radiology tests, including basic xrays, ultrasonography (USG), computed tomography (CT), magnetic resonance imaging (MRI), and specialized CT scans. Radiology facilities have 11 CT scanners and 4 MRI machines. Committed to accuracy and reliability, the Company supports healthcare professionals and patients by delivering essential diagnostic services. The Company launched the IPO aggregating an issuance of 67,52,000 equity shares of face value of Rs 10 each by raising Rs 106.98 Cr, comprising a fresh issue of 44,52,064 equity shares aggregating to Rs 70.41 Cr and the offer for sale of 22,96,936 equity shares aggregating to Rs 36.57 Cr in February, 2025.

Chandan Healthcare Financial Highlights


For the full year FY2025–2026, revenue reached ₹232.17 crore and profit touched at ₹23.52 crore.

Chandan Healthcare Share Price Today


As of 21 Jan 2026, Chandan Healthcare share price is ₹251.8. The stock opened at ₹250 and had closed at ₹257.6 the previous day. During today’s trading session, Chandan Healthcare share price moved between ₹247.00 and ₹262.00, with an average price for the day of ₹254.50. Over the last 52 weeks, the stock has recorded a low of ₹140.00 and a high of ₹358.00. In terms of performance, Chandan Healthcare share price has increased by 18.1% over the past six months and has increased by 54.47% over the last year.
Read More
View details of Market Depth

Chandan Healthcare Fundamental

Market Cap (in crs)

630.01

Face Value

10

Turnover (in lacs)

94.66

Key Metrics

Qtr Change %
-18.2
Dividend yield 1yr %
0

Chandan Healthcare Key Financials

View more
Loading chart...
Chandan Healthcare Quarterly Revenue
Chandan Healthcare Yearly Revenue
Chandan Healthcare Quarterly Net Profit/Loss
Chandan Healthcare Yearly Net Profit/Loss

Chandan Healthcare Shareholding Pattern

Promoter
49.5%
Domestic Institutions
4.8%
Public
45.8%

Chandan Healthcare Technical Analysis

Moving Averages Analysis
251.75
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
Day EMA5
265.20
Day EMA10
278.00
Day EMA12
281.30
Day EMA20
289.90
Day EMA26
293.60
Day EMA50
297.60
Day EMA100
285.60
Day EMA200
246.10
Delivery & Volume
Loading chart...

Day

70.20%

Week

68.40%

Month

65.30%

Delivery & Volume

253.58
Pivot
Resistance
First Resistance
260.17
Second Resistance
268.58
Third Resistance
275.17
Support
First Support
245.17
Second support
238.58
Third Support
230.17
Relative Strength Index
25.87
Money Flow Index
17.99
MACD
-12.28
MACD Signal
-6.25
Average True Range
15.13
Average Directional Index
28.51
Rate of Change (21)
-13.19
Rate of Change (125)
16.17
Compare

Chandan Healthcare Latest News

13 OCT 2025 | Monday
17 FEB 2025 | Monday
10 FEB 2025 | Monday

Please be aware that Chandan Healthcare stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account